Cart
sales@molnova.com
Granotapide
CAS No. 594842-13-4
Granotapide( —— )
Catalog No. M34613 CAS No. 594842-13-4
Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 739 | In Stock |
|
| 5MG | 504 | In Stock |
|
| 10MG | 728 | In Stock |
|
| 25MG | 1121 | In Stock |
|
| 50MG | 1479 | In Stock |
|
| 100MG | 2000 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3990 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGranotapide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGranotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.
-
DescriptionGranotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetCETP
-
RecptorCETP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number594842-13-4
-
Formula Weight718.71
-
Molecular FormulaC39H37F3N2O8
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(COC(CC1=CC(C(N(C)C)=O)=C(NC(=O)C2=C(C=CC=C2)C3=CC=C(C(F)(F)F)C=C3)C=C1)=O)(C(OCC)=O)(C(OCC)=O)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Anacetrapib
Anacetrapib (MK 0859) is a potent, orally active cholesteryl ester transfer protein (CETP) inhibitor with IC50 of 7.9 nM and 11.8 nM for rhCETP and C13S CETP mutant, respectively.
-
SR17018
SR17018 is an mu-opioid-receptor (MOR) agonist, binding with GTPγS, with an EC50 of 97 nM.
-
Ro 5-3335
Ro 5-3335 is core binding factor (CBF) inhibitor; preferentially kills human leukemia cell lines with CBF fusion proteins (IC50 = 1.1 μM).
